TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-203-A0201 Targeting PRAME August 30, 2023
Longwood Healthcare Leaders to Convene Top Biotech and Pharmaceutical Leaders and Researchers August 15, 2023
Werewolf Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update August 14, 2023
Results from XyloCor Therapeutics’ Phase 1 Portion of EXACT Trial of XC001 for Cardiovascular Disease Published in Circulation: Cardiovascular Interventions August 3, 2023
